Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. - Wikidata - awgldk - TriplyDB

Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.

Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.

http://www.wikidata.org/entity/Q35997721

about

Erythropoietin and diabetes mellitus Oxygen sensing in retinal health and disease Erythropoietin: new directions for the nervous system Erythropoietin in Friedreich ataxia Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy Erythropoietin improves the survival of fat tissue after its transplantation in nude mice Asialoerythropoietin is a strong modulator of angiogenesis by bone-marrow cells.Oxidative stress: Biomarkers and novel therapeutic pathways.New strategies for Alzheimer's disease and cognitive impairment.Diabetes mellitus: channeling care through cellular discovery Epo is relevant neither for microvascular formation nor for the new formation and maintenance of mice skeletal muscle fibres in both normoxia and hypoxia.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Erythropoietin after a century of research: younger than ever.Age-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietin.Erythropoietin (EPO) in acute kidney injury Systemic administration of erythropoietin inhibits retinopathy in RCS rats.Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3 mGluRI targets microglial activation and selectively prevents neuronal cell engulfment through Akt and caspase dependent pathways Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways.Regeneration in the nervous system with erythropoietin Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better?Vital elements of the Wnt-Frizzled signaling pathway in the nervous system.Cellular response to tissue hypoxia and its involvement in disease progression.Winding through the WNT pathway during cellular development and demise Erythropoietin deficiency decreases vascular stability in mice.Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide.Erythropoietin improves neuronal proliferation in dentate gyrus of hippocampal formation in an animal model of Alzheimer's disease.Novel renoprotective actions of erythropoietin: new uses for an old hormone.Erythropoietin and cerebral vascular protection: role of nitric oxide.Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.The Wnt signaling pathway: aging gracefully as a protectionist?Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies Mechanistic insights into diabetes mellitus and oxidative stress Charting a course for erythropoietin in traumatic brain injury.The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury."Sly as a FOXO": new paths with Forkhead signaling in the brain Erythropoietin and oxidative stress.Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling.

P2860

Q26777878-D95F8486-A4D0-45C6-9980-F29F5F2E63C9 Q26827518-6D67F09C-A674-4CDE-9D18-AD246290133F Q26828425-303DB277-C212-4076-8D7C-988E955A5C4F Q26863216-35166C53-5A81-4AD7-A2A1-982197B17736 Q28066377-779F55FB-C2C7-4A67-8B74-88FA0E0CD9C3 Q28748456-3903A5EE-4FF9-4D8E-8B55-8AA23C961DDB Q33311719-18EB3D1B-923E-4AED-9D3D-B2666E20E3C7 Q33682262-CDC98AD6-A6ED-4418-B122-EDD80A24024C Q33717008-E7254588-202E-4757-9FA2-F9D67E2C8CE5 Q33749358-EB8B9722-9D4B-463E-87A1-D67BCC10FD68 Q33791317-E8BAFEF9-DB53-419D-A52C-F5303E35A434 Q34552287-5300081B-9E83-4B44-B24B-4172174161F9 Q34606348-A21126E0-0F7A-496F-84E6-FB732ED797DD Q35017110-8E3ABD5A-B7BF-4584-82B2-6C948404B16C Q35176135-C0BCA554-5D9A-4556-A8A6-8FE2B94450A5 Q35224135-764C1A10-9BB7-4393-BC6A-83A300BC50F6 Q36002822-842E6F6B-0875-4E1F-99B8-B5BD330B256F Q36002849-991EBB5A-A6BB-439B-B846-3F587ADD7E4C Q36002879-5F132F01-CAF0-447F-BBD8-9A8D2D8D1D01 Q36002884-8AF41FA7-D774-425F-8BD1-949D76F8A638 Q36247651-5C06381C-A33B-473E-93E8-B232FC1BB818 Q36266206-10063555-C3FE-44D4-A90D-594843489E9A Q36266255-94A0D407-951A-4923-AA3A-2E7CF58AC1D0 Q36268487-FBAF6CBC-C9F0-4F0F-855B-E106FD6535B6 Q36305544-B2B0B773-9C22-40BC-B7F5-9251B1D65AD4 Q36404124-B02AC3B9-69F4-4D85-8D20-05D6231EBD04 Q36447198-E42961EB-46F3-4698-92E2-A1A8F18E7BE2 Q36529533-89DFF909-1B3C-485A-8EF8-09ECB746726B Q36556717-FF0A2C76-4EDF-4EE1-A97B-9A139E193B85 Q36627295-9E22FA7D-6186-41AD-8B5A-151B0CFF2858 Q36663152-5F9E4DE3-EB66-4988-9D76-B46A051FA7B7 Q36727444-9BAA89FE-2C50-4B5D-927B-40BC7459FF7F Q36728844-E9C8A177-C4C3-43F3-AB6E-5CDB28E0E984 Q36740470-99421EDF-0DA8-460D-8E98-9219DE980D54 Q36748171-1DC9B1BC-2132-432D-92E9-2B7920382A92 Q36791150-6A028139-0BC6-49FA-8D23-9266DFD2DDBC Q36836455-5D61FD2A-10AB-4211-9AD2-FC62F39EB333 Q36944469-7F9D339B-C80B-483E-9B14-83085AF7EB1F Q36944477-F1D295DB-1503-426B-8794-4550B4958C2A Q37182044-12E33D96-5445-4106-B5DF-539C353757C6

P2860

Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.

http://www.wikidata.org/entity/Q35997721

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Erythropoietin on a tightrope: ...... rinsic and extrinsic pathways.

@ast

Erythropoietin on a tightrope: ...... rinsic and extrinsic pathways.

@en

type

label

Erythropoietin on a tightrope: ...... rinsic and extrinsic pathways.

@ast

Erythropoietin on a tightrope: ...... rinsic and extrinsic pathways.

@en

prefLabel

Erythropoietin on a tightrope: ...... rinsic and extrinsic pathways.

@ast

Erythropoietin on a tightrope: ...... rinsic and extrinsic pathways.

@en

P1433

Q35997721-BAAD40D3-15CF-4BFB-BDCC-F76C42DEB62B

P1476

Q35997721-19396614-8552-4865-BE18-26FD447089A4

P2093

Q35997721-61966FC2-F61C-4FAC-868E-6A7D768DA8AB

Q35997721-6AA8723F-72AB-47CA-98F7-9D503D7DD4B2

Q35997721-884FAAE1-B6A8-4C36-A02B-4F5DC95C9D09

P2860

Q35997721-02C80F54-56DE-471D-AE51-0730009399BC

Q35997721-02FBC39C-B6FA-46AD-9991-E3A4D247195B

Q35997721-0737BC12-3DA9-4D33-929B-DA6CB59A9CF8

Q35997721-0A401F77-C807-48B7-94E6-B3245B141267

Q35997721-0A86006E-D785-43D8-99BF-5E560AF5C9C0

Q35997721-0B8F942E-252C-439E-B520-C363B3C26E78

Q35997721-0BEE10A5-2294-446C-A248-22B78C048DA9

Q35997721-0C5FA1A4-5E50-4F3F-B911-039B71EB8223

Q35997721-0D3FB636-140F-45B0-BE2C-BB9C0FF280D4

Q35997721-0E38744E-A4DC-4CE0-991E-5A8F09EB6A57

P304

Q35997721-D9329EE4-5570-4AA2-9E76-E2810C1FFE8E

P31

Q35997721-40210CF4-A3E2-43C7-8429-90C390BAD420

P356

Q35997721-6D2712FF-1EC3-4917-99FD-69E961615E34

P433

Q35997721-A16747D4-051F-46BE-93CC-0D0F253BC807

P478

Q35997721-8782B79A-F013-4B1A-B332-09058A84063C

P577

Q35997721-971DA103-4199-4765-8F42-BEB9A592A7FB

P698

Q35997721-8BA90FA3-A98C-49A3-8624-D54111FF3F98

P921

Q35997721-53FDEB72-D7CD-4DBF-8D41-DB5C389E72FB

P356

P1433

P1476

Erythropoietin on a tightrope: ...... rinsic and extrinsic pathways.

@en

P2093

Faqi Li

http://www.w3.org/2001/XMLSchema#string

Kenneth Maiese

http://www.w3.org/2001/XMLSchema#string

Zhao Zhong Chong

http://www.w3.org/2001/XMLSchema#string

P2860

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Isolation and characterization of genomic and cDNA clones of human erythropoietin

Hypoxia-inducible erythropoietin gene expression in human neuroblastoma cells

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase

Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin

P304

265-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000081963

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15627815

http://www.w3.org/2001/XMLSchema#string

P921